Source: ScienceDirect
There are currently no established postinjection recommendations for the use of platelet-rich plasma (PRP) as a treatment for knee osteoarthritis (OA). This paper systematically reviews postinjection protocols for randomized controlled trials of PRP for knee OA, with a particular focus on nonsteroidal anti-inflammatory drugs (NSAIDs) restrictions, activity limitations, and rehabilitation protocols.
